End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
37.11
CNY
|
+6.00%
|
|
+6.85%
|
-5.48%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,672
|
3,191
|
7,355
|
6,725
|
4,408
|
9,675
|
Enterprise Value (EV)
1 |
1,587
|
3,123
|
7,284
|
6,761
|
4,285
|
9,230
|
P/E ratio
|
39.8
x
|
83.1
x
|
131
x
|
170
x
|
82.6
x
|
112
x
|
Yield
|
0.72%
|
0.26%
|
0.17%
|
0.13%
|
0.24%
|
0.19%
|
Capitalization / Revenue
|
3.95
x
|
7.01
x
|
13.5
x
|
8.56
x
|
5.99
x
|
12.1
x
|
EV / Revenue
|
3.75
x
|
6.86
x
|
13.4
x
|
8.6
x
|
5.83
x
|
11.5
x
|
EV / EBITDA
|
34.3
x
|
58.6
x
|
100
x
|
112
x
|
64.1
x
|
69.2
x
|
EV / FCF
|
-26.7
x
|
299
x
|
719
x
|
-239
x
|
817
x
|
-103
x
|
FCF Yield
|
-3.75%
|
0.33%
|
0.14%
|
-0.42%
|
0.12%
|
-0.97%
|
Price to Book
|
3.82
x
|
6.89
x
|
14.4
x
|
11.2
x
|
5.74
x
|
7.77
x
|
Nbr of stocks (in thousands)
|
226,512
|
226,512
|
226,512
|
227,606
|
234,800
|
246,424
|
Reference price
2 |
7.380
|
14.09
|
32.47
|
29.55
|
18.77
|
39.26
|
Announcement Date
|
4/24/19
|
4/23/20
|
4/27/21
|
4/27/22
|
4/25/23
|
4/8/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
423
|
455.1
|
544
|
785.8
|
735.3
|
799.3
|
EBITDA
1 |
46.31
|
53.27
|
72.73
|
60.29
|
66.88
|
133.4
|
EBIT
1 |
41.86
|
44.98
|
60.07
|
44.27
|
49.27
|
115.3
|
Operating Margin
|
9.89%
|
9.88%
|
11.04%
|
5.63%
|
6.7%
|
14.43%
|
Earnings before Tax (EBT)
1 |
49.13
|
45.9
|
62.91
|
45.68
|
57.22
|
97.17
|
Net income
1 |
42.14
|
37.84
|
56.83
|
40
|
52.67
|
85.49
|
Net margin
|
9.96%
|
8.31%
|
10.45%
|
5.09%
|
7.16%
|
10.69%
|
EPS
2 |
0.1854
|
0.1695
|
0.2479
|
0.1736
|
0.2273
|
0.3500
|
Free Cash Flow
1 |
-59.51
|
10.45
|
10.13
|
-28.27
|
5.243
|
-89.44
|
FCF margin
|
-14.07%
|
2.3%
|
1.86%
|
-3.6%
|
0.71%
|
-11.19%
|
FCF Conversion (EBITDA)
|
-
|
19.62%
|
13.92%
|
-
|
7.84%
|
-
|
FCF Conversion (Net income)
|
-
|
27.63%
|
17.82%
|
-
|
9.95%
|
-
|
Dividend per Share
2 |
0.0530
|
0.0371
|
0.0551
|
0.0372
|
0.0455
|
0.0750
|
Announcement Date
|
4/24/19
|
4/23/20
|
4/27/21
|
4/27/22
|
4/25/23
|
4/8/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
36.2
|
-
|
-
|
Net Cash position
1 |
84.4
|
67.3
|
71.2
|
-
|
123
|
445
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
0.5996
x
|
-
|
-
|
Free Cash Flow
1 |
-59.5
|
10.5
|
10.1
|
-28.3
|
5.24
|
-89.4
|
ROE (net income / shareholders' equity)
|
9.97%
|
8.4%
|
11.7%
|
7.15%
|
7.42%
|
8.34%
|
ROA (Net income/ Total Assets)
|
5.02%
|
4.52%
|
4.36%
|
2.53%
|
2.6%
|
5.08%
|
Assets
1 |
839.1
|
838
|
1,302
|
1,580
|
2,024
|
1,681
|
Book Value Per Share
2 |
1.930
|
2.050
|
2.260
|
2.640
|
3.270
|
5.050
|
Cash Flow per Share
2 |
0.2000
|
0.3000
|
0.2300
|
0.4100
|
0.5500
|
1.530
|
Capex
1 |
62
|
20.7
|
14
|
13.8
|
33
|
208
|
Capex / Sales
|
14.65%
|
4.54%
|
2.57%
|
1.76%
|
4.49%
|
26.03%
|
Announcement Date
|
4/24/19
|
4/23/20
|
4/27/21
|
4/27/22
|
4/25/23
|
4/8/24
|
|
1st Jan change
|
Capi.
|
---|
| -5.48% | 1.26B | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|